Increase in retinal hypoxia-inducible factor-2α, but not hypoxia, early in the progression of diabetes in the rat

Experimental Eye Research

Volumn 93, Issue 4, 2011, Pages 437-441

  Wright, William S ^a,b   McElhatten, Robert M ^a   Harris, Norman R ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF SOUTH CAROLINA UPSTATE   (United States)

Author keywords

Diabetes; HIF 1 ; HIF 2 ; Hypoxia; Hypoxia inducible factor; Retina; Streptozotocin

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PIMONIDAZOLE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; RETINA BLOOD FLOW; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICROSCOPY, FLUORESCENCE; RATS; RATS, WISTAR; RETINAL VESSELS;

EID: 80055030000     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.06.003     Document Type: Article

References (33)

1. Arjamaa O., Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp. Eye Res. 2006, 83:473-483.
2. Bell E.L., Klimova T.A., Eisenbart J., Moraes C.T., Murphy M.P., Budinger G.R., Chandel N.S. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J. Cell Biol. 2007, 177:1029-1036.
3. Budzynski E., Wangsa-Wirawan N., Padnick-Silver L., Hatchell D., Linsenmeier R. Intraretinal pH in diabetic cats. Curr. Eye Res. 2005, 30:229-240.
4. Chen J., Nathans J. Genetic ablation of cone photoreceptors eliminates retinal folds in the retinal degeneration 7 (rd7) mouse. Invest. Ophthalmol. Vis. Sci. 2007, 48:2799-2805.
5. Curtis T.M., Gardiner T.A., Stitt A.W. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?. Eye (Lond) 2009, 23:1496-1508.
6. de Gooyer T.E., Stevenson K.A., Humphries P., Simpson D.A., Gardiner T.A., Stitt A.W. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:5561-5568.
7. Ding K., Scortegagna M., Seaman R., Birch D.G., Garcia J.A. Retinal disease in mice lacking hypoxia-inducible transcription factor-2alpha. Invest. Ophthalmol. Vis. Sci. 2005, 46:1010-1016.
8. Gubitosi-Klug R.A., Talahalli R., Du Y., Nadler J.L., Kern T.S. 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 2008, 57:1387-1393.
9. Holekamp N.M., Shui Y.B., Beebe D. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am. J. Ophthalmol. 2006, 141:1027-1032.
10. Holmquist-Mengelbier L., Fredlund E., Lofstedt T., Noguera R., Navarro S., Nilsson H., Pietras A., Vallon-Christersson J., Borg A., Gradin K., Poellinger L., Pahlman S. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 2006, 10:413-423.
11. Kanwar M., Chan P.S., Kern T.S., Kowluru R.A. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci. 2007, 48:3805-3811.
12. Kleiter M.M., Thrall D.E., Malarkey D.E., Ji X., Lee D.Y., Chou S.C., Raleigh J.A. A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. Int. J. Radiat. Oncol. Biol. Phys. 2006, 64:592-602.
13. Kowluru R.A., Kowluru V., Xiong Y., Ho Y.S. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic. Biol. Med. 2006, 41:1191-1196.
14. Lau J.C., Linsenmeier R.A. Oxygen consumption and distribution in the diabetic rat retina. Invest. Ophthalmol. Vis. Sci. 2010, 51. E-abstract 5644.
15. Lee S., Harris N.R. Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice. Microcirculation 2008, 15:379-387.
16. Lee S., Morgan G.A., Harris N.R. Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina. Microvasc. Res. 2008, 76:217-223.
17. Linsenmeier R.A., Braun R.D., McRipley M.A., Padnick L.B., Ahmed J., Hatchell D.L., McLeod D.S., Lutty G.A. Retinal hypoxia in long-term diabetic cats. Invest. Ophthalmol. Vis. Sci. 1998, 39:1647-1657.
18. Lisy K., Peet D.J. Turn me on: regulating HIF transcriptional activity. Cell Death Differ. 2008, 15:642-649.
19. Mowat F.M., Luhmann U.F., Smith A.J., Lange C., Duran Y., Harten S., Shukla D., Maxwell P.H., Ali R.R., Bainbridge J.W. HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS One 2010, 5:e11103.
20. Nishiguchi K.M., Kaneko H., Nakamura M., Kachi S., Terasaki H. Identification of photoreceptor precursors in the pars plana during ocular development and after retinal injury. Invest. Ophthalmol. Vis. Sci. 2008, 49:422-428.
21. Obrosova I.G., Drel V.R., Kumagai A.K., Szabo C., Pacher P., Stevens M.J. Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia 2006, 49:2525-2533.
22. Poulaki V., Joussen A.M., Mitsiades N., Mitsiades C.S., Iliaki E.F., Adamis A.P. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. Am. J. Pathol. 2004, 165:457-469.
23. Raleigh J.A., Koch C.J. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmacol 1990, 40:2457-2464.
24. Rimmer T., Linsenmeier R.A. Resistance of diabetic rat electroretinogram to hypoxemia. Invest. Ophthalmol. Vis. Sci. 1993, 34:3246-3252.
25. Small K.W., Stefansson E., Hatchell D.L. Retinal blood flow in normal and diabetic dogs. Invest. Ophthalmol. Vis. Sci. 1987, 28:672-675.
26. Waisbourd M., Goldstein M., Loewenstein A. Treatment of diabetic retinopathy with anti-VEGF drugs. Acta Ophthalmol 2011, 89:203-207.
27. Warnecke C., Zaborowska Z., Kurreck J., Erdmann V.A., Frei U., Wiesener M., Eckardt K.U. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 2004, 18:1462-1464.
28. Wright W.S., Harris N.R. Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina. Exp. Eye Res. 2008, 86:528-536.
29. Wright W.S., McElhatten R.M., Messina J.E., Harris N.R. Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats. Exp. Eye Res. 2010, 90:405-412.
30. Wright W.S., Messina J.E., Harris N.R. Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist. Exp. Eye Res. 2009, 88:106-112.
31. Yam J.C., Kwok A.K. Update on the treatment of diabetic retinopathy. Hong Kong Med. J. 2007, 13:46-60.
32. Zheng L., Du Y., Miller C., Gubitosi-Klug R.A., Ball S., Berkowitz B.A., Kern T.S. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 2007, 50:1987-1996.
33. Zhu B., Wang W., Gu Q., Xu X. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats. Exp. Eye Res. 2008, 86:375-382.